Delivery Order SPE2DB20D3101-SPE2DB23FRYL2

Award Date 9/21/23
Potential Completion Date 9/22/23
Potential Value $417
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency awarded a $436 delivery order to Amerisourcebergen Drug Corporation for Emgality 120 mg/ml pen injectors. The firm fixed price order is being fulfilled from the contractor's facility in Conshohocken, Pennsylvania for delivery by September 26, 2023 in support of the Defense Department's medical supply needs. Amerisourcebergen will provide the migraine treatment pens as the prime contractor under an unspecified multiple award contract vehicle with DLA. No set aside...
The Defense Logistics Agency awarded a $695.45 delivery order to Amerisourcebergen Drug Corporation for Emgality 120 mg/ml pen injectors. The firm fixed price order is being fulfilled from the contractor's facility in Conshohocken, Pennsylvania, with performance spanning July 24-25, 2023. No subcontractors or set aside designations were specified. The Defense Logistics Agency manages the Department of Defense's global supply chain and distribution network, suggesting this small order for...
The Defense Logistics Agency awarded a $834 delivery order to Amerisourcebergen Drug Corporation for Emgality 120 mg/ml pen injectors. The firm fixed price order is being fulfilled from the contractor's facility in Conshohocken, Pennsylvania, with performance spanning September 18-19, 2023. No subcontractors or set aside designations were indicated. The Defense Logistics Agency manages the Department of Defense's global logistics network and supply chain, procuring a wide range of...
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $417.27 to Amerisourcebergen Drug Corporation. The order is for 120 mg/ml Emgality pens and will be fulfilled from Amerisourcebergen's facility in Conshohocken, Pennsylvania by August 23, 2023. Emgality is a medication used to treat conditions such as migraine and cluster headache. The Defense Logistics Agency leverages contracts such as this to efficiently procure pharmaceuticals and other medical supplies for...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $139,000 to Amerisourcebergen Drug Corporation for Emgality 120 mg/ml pen injectors. As the prime contractor, Amerisourcebergen will deliver the pharmaceutical products to a location in Conshohocken, Pennsylvania by July 11, 2023 under the terms of the order. The Defense Logistics Agency functions to support military readiness by procuring and providing logistics support for critical supplies, likely...
The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $834 to Amerisourcebergen Drug Corporation. The order is for 120 mg/ml Emgality pens and will be fulfilled from Amerisourcebergen's facility in Conshohocken, Pennsylvania over a period of one day in August 2023. Emgality is used to treat conditions such as migraine and cluster headache. This order was issued under an existing DLA contract vehicle but details of the vehicle were not provided....
The Defense Logistics Agency awarded a $139,090 delivery order to Amerisourcebergen Drug Corporation for Emgality 120 mg/ml pen injectors. This firm fixed price order is being fulfilled under an existing prime vendor contract vehicle and will provide the requested pharmaceutical products to DLA from September 15-18, 2023. Amerisourcebergen will deliver Emgality pens from its facility in Conshohocken, Pennsylvania to an unknown customer or customers of the Defense Logistics Agency. No...
The Defense Logistics Agency awarded a delivery order valued at $556.36 to Amerisourcebergen Drug Corporation for Emgality 120 mg/ml pen injectors. As the prime contractor, Amerisourcebergen will deliver the pharmaceutical products to a location in Conshohocken, Pennsylvania by August 9, 2023 under a firm fixed price contract. No additional details were provided regarding subcontractors or the Defense Logistics Agency's programs that would provide helpful context for this small delivery order.
The Defense Logistics Agency awarded a firm fixed price delivery order valued at $417.27 to Amerisourcebergen Drug Corporation. The order is for 120 MG/ML Emgality pens and will be fulfilled from Amerisourcebergen's facility in Conshohocken, Pennsylvania by August 8, 2023. Emgality is a medication used to prevent migraine headaches. This delivery order was issued under the DLA's Pharmaceutical Prime Vendor contract, which establishes Amerisourcebergen as a primary supplier of prescription...
The Defense Logistics Agency awarded a $139,090 delivery order to Amerisourcebergen Drug Corporation for Emgality 120 mg/ml pen injectors. As a prime contractor for DLA's pharmaceutical supply chain programs, Amerisourcebergen will deliver the migraine treatment pens to a facility in Conshohocken, Pennsylvania under a firm fixed price contract running from August 16-17, 2023. No set aside designation or subcontractors were indicated. This supports DLA's mission to procure medical supplies for...
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB23FRYL2
    Delivery Order

The Defense Logistics Agency awarded a $417 firm fixed price delivery order to Amerisourcebergen Drug Corporation for Emgality 120 mg/ml pen injectors. As the prime contractor, Amerisourcebergen will deliver the pen injectors to its place of performance in Conshohocken, Pennsylvania by September 22, 2023 under the terms of this order. Emgality is used to treat conditions such as migraine and cluster headaches. The Defense Logistics Agency leverages contracts such as this to efficiently procure necessary pharmaceuticals and support the medical readiness of the U.S. armed forces.

Generated 12/21/23, 9:23 AM